Prevention & lipidsCohort study

Tailoring Risk Prediction Models to Local Populations

JAMA CardiolPublished

  • Retrospective cohort study
  • EHR-based
  • prediction model development and validation

Authors' conclusion

The interpretable ML approach presented in this article enhanced the accuracy of the AHA-PREVENT model when applied to a local population while still preserving the risk associations found by the original model.

Study context

Population
New England EHR cohort of patients without prior atherosclerotic cardiovascular disease (ASCVD), event period 2007–2016test set 38,137
Participants
95,326 participants
Exposure
MLM-PREVENT vs AHA-PREVENT equations
Outcome
ASCVD events (nonfatal MI, CAD, ischemic stroke or CV death); calibration, discrimination (Harrell C index) and reclassification
Follow-up
10-year

Main finding

As reported in the abstract

Calibration (modified Hosmer-Lemeshow)
overall; AHA-PREVENT χ23 > 16.3, P < .001
χ23 2.2; P = 0.53
men; AHA-PREVENT χ23 > 16.3, P < .001
χ23 2.1; P = 0.55
women; AHA-PREVENT χ23 > 16.3, P < .001
χ23 6.5; P = 0.09

Observational data: associations, not effects.

Further findings

OutcomeMLM-PREVENTAHA-PREVENT
Reclassification at 7.5% risk threshold11.5%Not reported in the abstract

Calibration by race

MLM-PREVENT maintained or improved calibration in Asian, Black and White individuals

Discrimination

Both models performed equally well (approximate ΔC index)
±0.01

Original publication

Tailoring Risk Prediction Models to Local Populations. JAMA Cardiol. Published 1 November 2024. doi:10.1001/jamacardio.2024.2912

Summarised from the published abstract; every number is checked against it